Related references
Note: Only part of the references are listed.Down-modulation of cancer targets using locked nucleic acid (LNA)-based antisense oligonucleotides without transfection
Y. Zhang et al.
GENE THERAPY (2011)
Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update
Ching-Hon Pui et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Antisense Inhibition of Survivin Expression as a Cancer Therapeutic
Rosa A. Carrasco et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Delivery of siRNA Therapeutics: Barriers and Carriers
Jie Wang et al.
AAPS JOURNAL (2010)
Survivin and IAP proteins in cell-death mechanisms
Dario C. Altieri
BIOCHEMICAL JOURNAL (2010)
Adult Acute Lymphoblastic Leukemia Concepts and Strategies
Stefan Faderl et al.
CANCER (2010)
Targeting survivin in cancer: patent review
Jagat R. Kanwar et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2010)
Overexpression of survivin initiates hematologic malignancies in vivo
S. Small et al.
LEUKEMIA (2010)
Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents
C. A. Stein et al.
NUCLEIC ACIDS RESEARCH (2010)
Down-Modulation of Survivin Expression and Inhibition of Tumor Growth In Vivo by EZN-3042, A Locked Nucleic Acid Antisense Oligonucleotide
Puja Sapra et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2010)
Survivin mediates aberrant hematopoietic progenitor cell proliferation and acute leukemia in mice induced by internal tandem duplication of Flt3
Seiji Fukuda et al.
BLOOD (2009)
The B Cell Mutator AID Promotes B Lymphoid Blast Crisis and Drug Resistance in Chronic Myeloid Leukemia
Lars Klemm et al.
CANCER CELL (2009)
Survivin as a global target of intrinsic tumor suppression networks
Minakshi Guha et al.
CELL CYCLE (2009)
Final stages of cytokinesis and midbody ring formation are controlled by BRUCE
Christian Pohl et al.
CELL (2008)
Acute lymphoblastic leukaemia
Ching-Hon Pui et al.
LANCET (2008)
SPC3042:: a proapoptotic survivin inhibitor
Jens Bo Hansen et al.
MOLECULAR CANCER THERAPEUTICS (2008)
IAPs: What's in a name?
Srinivasa M. Srinivasula et al.
MOLECULAR CELL (2008)
YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts
Takahito Nakahara et al.
CANCER RESEARCH (2007)
Centrosome aberrations after nilotinib and imatinib treatment in vitro are associated with mitotic spindle defects and genetic instability
Alice Fabarius et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Survivin mRNA antagonists using locked nucleic acid, potential for molecular cancer therapy
Niels Fisker et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2007)
Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children's Oncology Group study
Deepa Bhojwani et al.
BLOOD (2006)
Solution structure of human survivin and its binding interface with Smac/Diablo
CH Sun et al.
BIOCHEMISTRY (2005)
Rapid induction of mitochondrial events and caspase-independent apoptosis in Survivin-targeted melanoma cells
T Liu et al.
ONCOGENE (2004)
Essential role of survivin, an inhibitor of apoptosis protein, in T cell development, maturation, and homeostasis
Z Xing et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis
T Dohi et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
An IAP-IAP complex inhibits apoptosis
T Dohi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Pathways of apoptotic and non-apoptotic death in tumour cells
H Okada et al.
NATURE REVIEWS CANCER (2004)
Upregulation of survivin in G2/M cells and inhibition of caspase 9 activity enhances resistance in staurosporine-induced apoptosis
A Chandele et al.
NEOPLASIA (2004)
Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia
CH Pui et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Exploring the functional interactions between Aurora B, INCENP, and survivin in mitosis
R Honda et al.
MOLECULAR BIOLOGY OF THE CELL (2003)
Direct interaction between survivin and Smac/DIABLO is essential for the anti-apoptotic activity of survivin during taxol-induced apoptosis
ZY Song et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
HBXIP functions as a cofactor of survivin in apoptosis suppression
H Marusawa et al.
EMBO JOURNAL (2003)
Validating survivin as a cancer therapeutic target
DC Altieri
NATURE REVIEWS CANCER (2003)
The Survivin/Aurora B Complex Its Role in Coordinating Tension and Attachment
Susanne M. A. Lens et al.
CELL CYCLE (2003)
IAP proteins: Blocking the road to death's door
GS Salvesen et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Cytokine-regulated expression of survivin in myeloid leukemia
BZ Carter et al.
BLOOD (2001)
An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and-7
S Shin et al.
BIOCHEMISTRY (2001)
Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995
PS Gaynon et al.
LEUKEMIA (2000)
The survivin-like C-elegans BIR-1 protein acts with the aurora-like kinase AIR-2 to affect chromosomes and the spindle midzone
EK Speliotes et al.
MOLECULAR CELL (2000)
Share Paper
